Vencanna Ventures Inc
VENI
Critical Reagent Processing Corp
CRPC
Sanu Gold Corp
SANU
Cannibble Food Tech Ltd
PLCN
Fineqia International Inc
FNQ
CA Stock MarketDetailed Quotes
HLS HLS Therapeutics Inc
- 3.560
- -0.050-1.39%
15min DelayMarket Closed Dec 2 16:00 ET
113.18MMarket Cap-3815P/E (TTM)
3.610High3.550Low7.82KVolume3.580Open3.610Pre Close27.84KTurnover5.48052wk High0.04%Turnover Ratio31.79MShares3.00052wk Low-0.933EPS TTM68.67MFloat Cap24.598Historical HighLossP/E (Static)19.29MShs Float0.043Historical Low-1.127EPS LYR1.66%Amplitude--Dividend TTM1.02P/B1Lot Size--Div YieldTTM
HLS Therapeutics Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -72.03%1.5M | -5.58%2.52M | -80.65%778K | -6.81%15.79M | 6.05%3.73M | 29.29%5.37M | -24.03%2.67M | -30.18%4.02M | 3.12%16.94M | -11.49%3.52M |
| Net income from continuing operations | 29.81%-4.84M | 39.79%-5.68M | -5.42%-6.11M | -16.67%-27.53M | 15.99%-5.4M | -56.49%-6.9M | -3.22%-9.44M | -60.18%-5.79M | -79.90%-23.6M | -53.51%-6.43M |
| Operating gains losses | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -32.89%5.51M | -30.00%5.86M | -28.85%5.92M | -7.16%31.94M | -18.93%7.05M | -7.10%8.21M | -1.45%8.37M | -0.81%8.32M | 13.67%34.4M | 8.04%8.69M |
| Asset impairment expenditure | --0 | ---- | ---- | 27.60%3.89M | --1.54M | --0 | ---- | ---- | --3.05M | --0 |
| Unrealized gains and losses of investment securities | -99.11%18K | -44.21%318K | -66.06%187K | 223.95%2.89M | -210.97%-263K | 611.34%2.03M | 181.90%570K | 137.38%551K | -18.27%-2.33M | 129.74%237K |
| Remuneration paid in stock | 2,789.47%511K | 211.68%427K | 565.45%256K | -118.41%-538K | -179.92%-601K | -115.20%-19K | -88.86%137K | -106.75%-55K | 24.13%2.92M | 42.16%752K |
| Deferred tax | 91.31%-47K | 4,642.35%3.86M | 65.54%-61K | -604.35%-696K | 212.63%107K | -176.02%-541K | -525.00%-85K | -143.28%-177K | -87.85%138K | -115.40%-95K |
| Other non cashItems | 77.39%353K | 45.79%277K | 47.64%282K | -1.60%797K | 9.60%217K | -0.50%199K | -7.32%190K | -7.73%191K | 3.45%810K | -3.88%198K |
| Change In working capital | -99.92%2K | 46.61%843K | -69.38%301K | 225.60%5.04M | 554.82%1.09M | 47,940.00%2.39M | 61.52%575K | -4.56%983K | 151.21%1.55M | 138.25%166K |
| -Change in receivables | -207.54%-1.24M | 120.34%346K | -21.33%837K | 377.44%738K | 128.96%221K | 1,168.13%1.15M | -183.50%-1.7M | 5.77%1.06M | -125.48%-266K | -238.48%-763K |
| -Change in inventory | 19.41%1.22M | 70.83%1.19M | 56.35%-770K | -6.27%-661K | -149.52%-613K | 291.37%1.02M | 138.77%696K | -476.92%-1.76M | -135.18%-622K | 42.30%1.24M |
| -Change in payables and accrued expense | -46.13%842K | -286.16%-1.12M | -134.86%-495K | -27.72%2.27M | 34.01%-423K | 901.92%1.56M | -107.99%-289K | 14,100.00%1.42M | 176.75%3.14M | 65.28%-641K |
| -Change in other current assets | 279.35%588K | -126.59%-750K | 810.00%273K | 217.75%199K | 131.54%345K | -46.37%155K | 58.10%-331K | -83.61%30K | 75.68%-169K | --149K |
| -Change in other working capital | 6.33%-1.41M | -46.64%1.17M | 95.71%456K | 562.83%2.49M | 750.82%1.56M | -18,650.00%-1.5M | 2,994.74%2.2M | 136.58%233K | 48.47%-538K | -22.46%183K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -72.03%1.5M | -5.58%2.52M | -80.65%778K | -6.81%15.79M | 6.05%3.73M | 29.29%5.37M | -24.03%2.67M | -30.18%4.02M | 3.12%16.94M | -11.49%3.52M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -3,650.00%-1.5M | 9,914.81%13.25M | -2K | 98.14%-189K | 30.00%-14K | 99.60%-40K | -66.67%-135K | 0 | -125.01%-10.15M | 95.26%-20K |
| Net PPE purchase and sale | --0 | --0 | ---2K | 8.89%-41K | -55.56%-14K | --0 | -80.00%-27K | --0 | 4.26%-45K | 59.09%-9K |
| Net intangibles purchas and sale | --0 | ---- | ---- | 98.54%-148K | --0 | 99.60%-40K | ---- | ---- | -126.37%-10.1M | 97.25%-11K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -3,650.00%-1.5M | 9,914.81%13.25M | ---2K | 98.14%-189K | 30.00%-14K | 99.60%-40K | -66.67%-135K | --0 | -125.01%-10.15M | 95.26%-20K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -251.81%-15.1M | 12.48%-2.58M | 13.66%-3.03M | -113.52%-14.64M | 5.08%-3.89M | -167.77%-4.29M | 38.54%-2.95M | 18.22%-3.51M | 39.85%-6.86M | 1.82%-4.09M |
| Net issuance payments of debt | -548.45%-15.1M | -3.75%-1.61M | 2.80%-2.22M | -2,045.80%-9.46M | -29.60%-3.31M | -127.55%-2.33M | 51.35%-1.55M | 27.76%-2.28M | 96.04%-441K | 19.30%-2.55M |
| Net common stock issuance | --0 | -71.35%-317K | -53.80%-283K | -55.51%-1.55M | -65.71%-580K | -123.33%-603K | 48.18%-185K | -776.19%-184K | -2,023.40%-998K | ---350K |
| Cash dividends paid | --0 | --0 | --0 | 51.67%-2.4M | --0 | --0 | 4.03%-1.22M | 7.80%-1.18M | 3.12%-4.96M | 5.99%-1.19M |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | -27.17%134K | --0 | --0 | --0 | -18.79%134K | -96.25%184K | --0 |
| Net other financing activities | --0 | ---658K | ---533K | -112.83%-1.36M | --0 | ---- | ---- | ---- | ---639K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -251.81%-15.1M | 12.48%-2.58M | 13.66%-3.03M | -113.52%-14.64M | 5.08%-3.89M | -167.77%-4.29M | 38.54%-2.95M | 18.22%-3.51M | 39.85%-6.86M | 1.82%-4.09M |
| Net cash flow | ||||||||||
| Beginning cash position | 55.34%32.52M | -8.35%19.44M | 5.93%21.95M | -2.15%20.72M | 2.49%21.81M | -1.08%20.93M | -6.40%21.21M | -2.15%20.72M | 2.75%21.18M | -2.10%21.28M |
| Current changes in cash | -1,557.05%-15.1M | 3,278.07%13.19M | -546.25%-2.26M | 1,650.00%961K | 72.01%-166K | 119.96%1.04M | 69.62%-415K | -64.52%506K | -111.90%-62K | 3.42%-593K |
| Effect of exchange rate changes | 175.00%120K | -187.97%-117K | -1,573.33%-251K | 168.02%268K | 737.84%310K | 54.55%-160K | 196.38%133K | -125.42%-15K | -956.52%-394K | -35.09%37K |
| End cash Position | -19.57%17.54M | 55.34%32.52M | -8.35%19.44M | 5.93%21.95M | 5.93%21.95M | 2.49%21.81M | -1.08%20.93M | -6.40%21.21M | -2.15%20.72M | -2.15%20.72M |
| Free cash from | -71.82%1.5M | -0.55%2.52M | -80.70%776K | 129.61%15.6M | 6.26%3.72M | 190.89%5.33M | -26.17%2.53M | -29.76%4.02M | -43.00%6.79M | -1.55%3.5M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.